BC
SPPI

Broadfin Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Broadfin Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,516,748
Closed -$15.1M – 96
2015
Q3 		$15.1M Sell
2,516,748
-133,252
-5% -$925K 0.84% 26
2015
Q2 		$18.1M Buy
2,650,000
+1,850,000
+231% +$11.7M 0.97% 27
2015
Q1 		$4.86M Buy
+800,000
New +$5.32M 0.38% 65

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital's SPPI Position: Q4 2015 in Review

Broadfin Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2015, closing a stake of 2,516,748 shares — an estimated $15.1M sold.

Broadfin Capital first reported a position in SPPI in Q1 2015 and held it in 3 quarters. The position peaked at $18.1M in Q2 2015. 146 funds tracked by Wall St. Rank hold SPPI as of Q4 2015.

  • Broadfin Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Broadfin Capital sold 2,516,748 Spectrum Pharmaceuticals Inc shares in Q4 2015, an estimated $15.1M.
  • Broadfin Capital first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 3 quarters.
  • Broadfin Capital's Spectrum Pharmaceuticals Inc position peaked at $18.1M in Q2 2015.
  • 146 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2015.

Based on Broadfin Capital's 13F filing for Q4 2015, filed 16 Feb 2016.